The Drug Development, Pharmacokinetics and Imaging module is a one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for ...
Devyani Deshpande, Jotam G. Pasipanodya, Stellah G. Mpagama, Shashikant Srivastava, Paula Bendet, Thearith Koeuth, Pooi S. Lee, Scott K. Heysell, Tawanda Gumbo ...
To develop and evaluate a whole-body physiologically based pharmacokinetic (WB-PBPK) model of bisoprolol and to simulate its exposure and disposition in healthy adults and patients with renal function ...
A large body of data indicates that (±)3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) can damage brain serotonin neurons in animals. However, the relevance of these preclinical data to humans is ...
SEATTLE, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical stage biopharmaceutical company developing innovative medicines in areas of ...
In drug discovery trials, the potential for a molecule to do harm to an organism must be known accurately. Understanding how a substance under investigation behaves once in the body informs the design ...
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback